PPD is a contract research organization that provides comprehensive, integrated drug development, laboratory and lifecycle management services to pharmaceutical, biotechnology, medical device, academic and government organizations.

AHRM is a specialty CRO that focuses on Health Economics and Outcomes Research. The company integrates and conducts clinical trials and outcomes research across various therapeutic areas.

Applied Healthcare Research Management Inc. (AHRM)

Prenosis develops precision medicine tools and implements them in real time for acute care settings, focusing on personalizing healthcare based on individual biology. They leverage their Immunix precision medicine platform and have created the FDA authorized Sepsis ImmunoScore.

Prenosis

Signant Health provides clinical trial technology and services, focusing on clinical data collection, patient engagement, clinical IP management, and analytics. Signant Health offers tailored solutions to meet specific protocol requirements.

Signant Health

Accelerated Enrollment Solutions

Evidera

PPD Biotech Solutions

PPD Laboratory Services

PPD is part of Thermo Fisher Scientific, the world leader in serving science. Together, Thermo Fisher and its PPD clinical research business are creating a unique opportunity to advance their shared pursuit to enable customers to make the world healthier by accelerating the development of new medicines. We offer a comprehensive suite of world-class services across the clinical development spectrum – from scientific discovery, to assessing safety, efficacy, and health care outcomes, to managing clinical trial logistics, to the development and manufacturing of the drug product. 

Science 37

🗳️ Last week to vote! » https://bit.ly/46V4v5I

We're honored to be considered for the Society for Clinical Research Sites (SCRS) Eagle Award, which recognizes outstanding leadership, professionalism, integrity, passion and dedication to advancing the clinical research profession through strong site partnerships.

We're grateful for the collaborative relationships with our site partners, and if you feel we have met these exceptional standards, we would be humbled to receive your vote for best CRO.

Our colleagues are enjoying connecting and sharing insights at #AAIC24 in Philadelphia. Let's unlock the future of memory care together. Find our team at booth 920!

📢 #AAIC24: Meet our Alzheimer's clinical research specialists at booth 920 this week in Philadelphia!

Our #pediatric experts are dedicated to maximizing efficiency, ensuring patient safety and achieving your study goals. With customized strategies tailored specifically for pediatric research, we strive to provide a seamless and successful trial experience. Our team is equipped with subject matter expertise and operational capabilities to help your pediatric #clinicaltrials meet study timelines.

Discover how we can help you reach your objectives. » https://bit.ly/3LPDSFL

In early #clinicaldevelopment, transparency around the research question of interest – the #estimand – is key. An estimand is a precise description of the treatment effect to be summarized in your research. From this white paper you'll learn why they're relevant in #clinicalpharmacology trials, key steps in the estimand thinking process, how they aid in clarifying R&D goals, and their growing use in #clinicaltrial protocols following new #regulatoryguidance. » https://bit.ly/3A6yJqd

For years, clinical trials have not accurately reflected the diversity within our population, leading to inequities in healthcare and scientific research. Yesterday, we hosted a Congressional briefing with industry leaders and patient advocates dedicated to bridging the gap for a more equitable future in science.  
 
Thank you to our panelists: Thermo Fisher Scientific’s Dr. Rose Blackburne, MD, MBA, Vice President, Medical Science and Strategy, and Global Head of General Medicine and Women’s Health, Vanderbilt University Medical Center’s Dr. Sheila Kusnoor, National Minority Quality Forum’s Dr. Salvatore (Salvo) Alesci and Cystic Fibrosis Foundation’s Ashleigh Tharp. Cross-industry collaboration is essential to support scientific discovery and understand how we can better connect communities to ongoing research and treatment discovery.

Metric
Company Name	PPD	Applied Healthcare Research Management Inc. (AHRM)	Prenosis	Signant Health
Symbol
MSH ID	COM:PPD	COM:AHRMINC	COM:PRENOSIS	COM:SIGNANTHEALTH
Market	PRIVATE	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services
Industry	Contract Research Organization (CRO)	Contract Research Organization (CRO)	Biotechnology	Clinical Research and Development
Country	US	US	US	US
Stage
Employee Count	26.54K			1.00K
Website	ppd.com	ahrminc.com	prenosis.com	signanthealth.com
LinkedIn	ppd	applied-healthcare-resource-management	prenosis
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic				43.77K
Web Traffic Growth				0.55
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:PPD

PPD

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue